Related Experiment Videos
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats
Life Sciences
|April 16, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Demyelinating Charcot-Marie-Tooth neuropathy associated with FBLN5 mutations.
European journal of neurology·2020
Novel SBF2 mutations and clinical spectrum of Charcot-Marie-Tooth neuropathy type 4B2.
Clinical genetics·2018
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose.
Translational psychiatry·2016
Recent Advances in Diabetes Therapies in Asia.
Diabetes care·2026
Electrostatics and Charge Regulation Drive Phosphate Accumulation in Cationic Dendrimers.
ACS applied polymer materials·2026
Characterization of TRPV2-associated pathology in Parkinson's disease and therapeutic modulation using Tranilast.
Frontiers in cellular neuroscience·2026
The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and 177Lu-PSMA Therapy Between Centers in Brazil and Europe.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
DoE-guided comparison of SNEDDS, solid dispersion, and polymeric nanoparticles for enhancing apparent epithelial transport and oral exposure of sorafenib.
Journal of pharmaceutical sciences·2026